| Product NDC: | 0781-5276 |
| Proprietary Name: | Donepezil Hydrochloride |
| Non Proprietary Name: | donepezil hydrochloride |
| Active Ingredient(s): | 5 mg/1 & nbsp; donepezil hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0781-5276 |
| Labeler Name: | Sandoz Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091198 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110510 |
| Package NDC: | 0781-5276-31 |
| Package Description: | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (0781-5276-31) |
| NDC Code | 0781-5276-31 |
| Proprietary Name | Donepezil Hydrochloride |
| Package Description | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (0781-5276-31) |
| Product NDC | 0781-5276 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | donepezil hydrochloride |
| Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
| Route Name | ORAL |
| Start Marketing Date | 20110510 |
| Marketing Category Name | ANDA |
| Labeler Name | Sandoz Inc |
| Substance Name | DONEPEZIL HYDROCHLORIDE |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |